Naxitamab

Records for this ingredient, by country (identity only).

ATC L01FX21 · 2 markets · 2 records

Naxitamab 2 markets · 2 records Forms

Filters

MarketUS 1 HK 1

Strength

US 1 records · 1 shown of 1 Source openFDA NDC Directory · Data as of 2026-10-23

40 mg/10 mLinjectionDANYELZA

HK 1 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名DANYELZA CONCENTRATE FOR SOLUTION FOR INFUSION 40MG/10ML ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.